Core Viewpoint - The article discusses the ongoing controversy surrounding Aikang Guobin, highlighting the trust crisis in the health checkup industry and the implications for both consumers and companies involved in health screenings [2][5][6]. Group 1: Aikang Guobin Incident - Aikang Guobin has officially sued lawyer Zhang Xiaoling for defamation, seeking 10 million yuan in damages [2]. - Zhang Xiaoling, diagnosed with late-stage cancer, criticized Aikang Guobin for failing to alert her to cancer risks during her ten years of health checkups [4]. - The incident has escalated public discourse on the effectiveness and reliability of health checkups, particularly in light of Aikang Guobin's CEO's controversial remarks [4][5]. Group 2: Trust Crisis in Health Checkups - Many young individuals express skepticism towards routine health checkups, with 45.2% of surveyed youth fearing potential health issues being discovered [9]. - The majority of health checkup clients are corporate group checkups, which account for 70-80% of the business, leading to a focus on cost-effective services rather than comprehensive health assessments [11][12]. - Budget constraints often limit the scope of health checks, with most corporate budgets falling below 1,000 yuan, impacting the detection of serious health conditions [13][14]. Group 3: Limitations of Routine Health Checkups - Routine health checkups primarily identify common chronic diseases and early signs of certain tumors, but they are not designed to detect rare diseases [41][31]. - The detection capabilities of routine checkups are limited, often requiring further targeted testing for confirmation of any health issues identified [25][41]. - The industry faces challenges in addressing the needs of diverse populations, as many checkup programs lack specificity and fail to consider individual health risks [15][16]. Group 4: Future of the Health Checkup Industry - The health checkup market is projected to exceed 3 trillion yuan by 2028, with a compound annual growth rate of 12.5% from 2023 to 2028 [43]. - The aging population will drive demand for chronic disease management and early cancer screening, becoming a key growth factor for the industry [44]. - The industry is shifting towards more personalized and refined health checkup services, moving away from a one-size-fits-all approach [53][54].